- Home
- OBK vs INVA Comparison
OBK vs INVA Comparison
Compare OBK & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBK
- INVA
- Stock Information
- Founded
- OBK 1912
- INVA 1996
- Country
- OBK United States
- INVA United States
- Employees
- OBK N/A
- INVA N/A
- Industry
- OBK Major Banks
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- OBK Finance
- INVA Health Care
- Exchange
- OBK Nasdaq
- INVA Nasdaq
- Market Cap
- OBK 1.0B
- INVA 1.2B
- IPO Year
- OBK 2018
- INVA 2004
- Fundamental
- Price
- OBK $34.13
- INVA $19.57
- Analyst Decision
- OBK Buy
- INVA Buy
- Analyst Count
- OBK 5
- INVA 1
- Target Price
- OBK $42.20
- INVA $55.00
- AVG Volume (30 Days)
- OBK 127.7K
- INVA 637.7K
- Earning Date
- OBK 07-23-2025
- INVA 05-07-2025
- Dividend Yield
- OBK 1.76%
- INVA N/A
- EPS Growth
- OBK N/A
- INVA N/A
- EPS
- OBK 2.43
- INVA N/A
- Revenue
- OBK $351,348,000.00
- INVA $369,844,000.00
- Revenue This Year
- OBK $13.16
- INVA $3.75
- Revenue Next Year
- OBK $6.03
- INVA $12.62
- P/E Ratio
- OBK $14.02
- INVA N/A
- Revenue Growth
- OBK 2.92
- INVA 18.70
- 52 Week Low
- OBK $28.80
- INVA $15.32
- 52 Week High
- OBK $41.17
- INVA $21.28
- Technical
- Relative Strength Index (RSI)
- OBK 57.76
- INVA 71.81
- Support Level
- OBK $33.67
- INVA $18.59
- Resistance Level
- OBK $34.43
- INVA $19.08
- Average True Range (ATR)
- OBK 0.71
- INVA 0.39
- MACD
- OBK 0.05
- INVA 0.08
- Stochastic Oscillator
- OBK 66.51
- INVA 94.89
About OBK Origin Bancorp Inc.
Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.